Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02753764 · ClinicalTrials.gov registry record · Phase 2
Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma
A Phase 2 study, sponsored by National Jewish Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT02753764: Completed Phase 2 study, sponsored by National Jewish Health.
NCT02753764 is a Phase 2 study that has completed, run by National Jewish Health. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02753764, a Phase 2 study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a double-blind, placebo controlled 4 week crossover study to investigate the efficacy and safety of AZD7624 (an inhaled p38 inhibitor) in corticosteroid resistant (CR) asthmatics. For the purpose of this study 10 symptomatic CR asthma patients with a FEV1% predicted \<80% and normal bronchodilator response, 10 CS asthmatics and 10 healthy controls will be recruited.
Interventions
- DRUG Placebo
- DRUG prednisone
- DRUG AZD7624
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-02-25 |
| Phase | Phase 2 |
What the finished NCT02753764 record still lists
NCT02753764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02753764 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02753764 about?
NCT02753764 is a clinical study titled "Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma". This is a double-blind, placebo controlled 4 week crossover study to investigate the efficacy and safety of AZD7624 (an inhaled p38 inhibitor) in corticosteroid resistant (CR) asthmatics. For the purpose of this study 10 symptomatic CR asthma patients with a FEV1% predicted \<80% and normal bronchod...
What is the current status of trial NCT02753764?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2017-01. Estimated completion is 2019-02-25.
What interventions are being tested in trial NCT02753764?
The interventions under investigation include: Placebo (DRUG), prednisone (DRUG), AZD7624 (DRUG).
Who is sponsoring clinical trial NCT02753764?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02753764's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia